JP2023116739A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023116739A5 JP2023116739A5 JP2023100171A JP2023100171A JP2023116739A5 JP 2023116739 A5 JP2023116739 A5 JP 2023116739A5 JP 2023100171 A JP2023100171 A JP 2023100171A JP 2023100171 A JP2023100171 A JP 2023100171A JP 2023116739 A5 JP2023116739 A5 JP 2023116739A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- hinge region
- peptide according
- seq
- helical domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762448358P | 2017-01-19 | 2017-01-19 | |
| US62/448,358 | 2017-01-19 | ||
| US201762476535P | 2017-03-24 | 2017-03-24 | |
| US201762476531P | 2017-03-24 | 2017-03-24 | |
| US62/476,531 | 2017-03-24 | ||
| US62/476,535 | 2017-03-24 | ||
| PCT/US2018/014532 WO2018136803A1 (en) | 2017-01-19 | 2018-01-19 | Apoc-ii mimetic peptides |
| JP2019539809A JP7353973B2 (ja) | 2017-01-19 | 2018-01-19 | Ａｐｏｃ－ｉｉ模倣ペプチド |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019539809A Division JP7353973B2 (ja) | 2017-01-19 | 2018-01-19 | Ａｐｏｃ－ｉｉ模倣ペプチド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023116739A JP2023116739A (ja) | 2023-08-22 |
| JP2023116739A5 true JP2023116739A5 (https=) | 2023-12-05 |
Family
ID=62908746
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019539809A Active JP7353973B2 (ja) | 2017-01-19 | 2018-01-19 | Ａｐｏｃ－ｉｉ模倣ペプチド |
| JP2023100171A Pending JP2023116739A (ja) | 2017-01-19 | 2023-06-19 | Ａｐｏｃ－ｉｉ模倣ペプチド |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019539809A Active JP7353973B2 (ja) | 2017-01-19 | 2018-01-19 | Ａｐｏｃ－ｉｉ模倣ペプチド |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11136372B2 (https=) |
| EP (1) | EP3571216A4 (https=) |
| JP (2) | JP7353973B2 (https=) |
| KR (1) | KR102700862B1 (https=) |
| CN (1) | CN110831957B (https=) |
| AU (1) | AU2018210404B2 (https=) |
| BR (1) | BR112019014707A2 (https=) |
| CA (1) | CA3050106A1 (https=) |
| IL (2) | IL268093B2 (https=) |
| MX (1) | MX2019008529A (https=) |
| NZ (1) | NZ755599A (https=) |
| SG (2) | SG10201911974UA (https=) |
| TW (2) | TW202130652A (https=) |
| WO (1) | WO2018136803A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202130652A (zh) | 2017-01-19 | 2021-08-16 | 美國衛生與公眾服務部 | Apoc-ii擬肽 |
| CN117580857A (zh) * | 2021-06-23 | 2024-02-20 | 美国政府(由卫生和人类服务部的部长所代表) | Apoc-ii短模拟肽及使用方法 |
| IL316418A (en) * | 2022-05-05 | 2024-12-01 | Us Health | Short apolipoprotein E mimetic peptides and methods of use |
| WO2024036145A1 (en) * | 2022-08-07 | 2024-02-15 | Protean Bio, Inc. | Peptides for beta-cell survival and insulin production |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
| US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
| US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
| EP0206448B1 (en) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
| US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
| US6156727A (en) * | 1996-09-05 | 2000-12-05 | Uab Research Foundation | Anti-atherosclerotic peptides and a transgenic mouse model of antherosclerosis |
| PL372925A1 (en) * | 2001-09-28 | 2005-08-08 | Esperion Therapeutics Inc. | Prevention and treatment of restenosis by local administration of drug |
| US7220576B2 (en) * | 2002-01-07 | 2007-05-22 | Lifesensors, Inc. | Methods and compositions for protein expression and purification |
| AU2004207444B2 (en) * | 2003-01-17 | 2008-07-31 | Merck & Co., Inc. | N-cyclohexylaminocarbonyl benzenesulfonamide derivatives |
| CA2549529A1 (en) * | 2003-12-15 | 2005-06-30 | The Regents Of The University Of California | Helical synthetic peptides that stimulate cellular cholesterol efflux |
| CN100567270C (zh) * | 2004-02-19 | 2009-12-09 | 万有制药株式会社 | 磺酰胺衍生物 |
| KR101185609B1 (ko) * | 2004-07-16 | 2012-09-24 | 트러스티즈 오브 터프츠 칼리지 | 아포리포단백질 ａ１ 미메틱 및 이의 용도 |
| AU2006263332B2 (en) * | 2005-06-29 | 2012-02-23 | Hadasit Medical Research Services & Development Ltd. | Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes |
| WO2008039843A2 (en) * | 2006-09-26 | 2008-04-03 | Lipid Sciences, Inc. | Novel peptides that promote lipid efflux |
| WO2009097584A1 (en) | 2008-01-30 | 2009-08-06 | Proteogenix, Inc. | Maternal serum biomarkers for detection of pre-eclampsia |
| US8936787B2 (en) * | 2008-04-15 | 2015-01-20 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Peptides promoting lipid efflux |
| US20120270771A1 (en) | 2009-09-30 | 2012-10-25 | Snu R&Db Foundation | Apolipoprotein a-1 mimic peptides, and therapeutic agent for treating hyperlipidemia and diseases related to hyperlipidemia comprising same |
| ES2859559T3 (es) * | 2012-11-06 | 2021-10-04 | Les Hopitaux Univ De Geneve | Péptidos miméticos |
| TW202130652A (zh) | 2017-01-19 | 2021-08-16 | 美國衛生與公眾服務部 | Apoc-ii擬肽 |
| EA201991491A1 (ru) | 2017-03-24 | 2019-12-30 | Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сервисис | Миметические пептиды apoc-ii |
-
2018
- 2018-01-19 TW TW109138699A patent/TW202130652A/zh unknown
- 2018-01-19 TW TW107102123A patent/TWI788323B/zh active
- 2018-01-19 SG SG10201911974UA patent/SG10201911974UA/en unknown
- 2018-01-19 MX MX2019008529A patent/MX2019008529A/es unknown
- 2018-01-19 KR KR1020197024024A patent/KR102700862B1/ko active Active
- 2018-01-19 IL IL268093A patent/IL268093B2/en unknown
- 2018-01-19 US US16/479,183 patent/US11136372B2/en active Active
- 2018-01-19 AU AU2018210404A patent/AU2018210404B2/en active Active
- 2018-01-19 CN CN201880019604.7A patent/CN110831957B/zh active Active
- 2018-01-19 NZ NZ755599A patent/NZ755599A/en unknown
- 2018-01-19 CA CA3050106A patent/CA3050106A1/en active Pending
- 2018-01-19 JP JP2019539809A patent/JP7353973B2/ja active Active
- 2018-01-19 SG SG11201906422VA patent/SG11201906422VA/en unknown
- 2018-01-19 WO PCT/US2018/014532 patent/WO2018136803A1/en not_active Ceased
- 2018-01-19 BR BR112019014707A patent/BR112019014707A2/pt unknown
- 2018-01-19 EP EP18742118.5A patent/EP3571216A4/en active Pending
-
2020
- 2020-12-29 IL IL279831A patent/IL279831A/en unknown
-
2021
- 2021-03-09 US US17/195,766 patent/US11827690B2/en active Active
-
2023
- 2023-06-19 JP JP2023100171A patent/JP2023116739A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023116739A5 (https=) | ||
| CA2387184C (en) | Cell-permeable peptide inhibitors of the jnk signal transduction pathway | |
| JP2021506814A5 (https=) | ||
| JP2003503312A5 (https=) | ||
| CA2370289A1 (en) | Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides | |
| CA2945838C (en) | Modified relaxin b chain peptides | |
| IL192046A (en) | Intact and peptide intestinal fragments and methods of use | |
| CN101490081A (zh) | 用于抑制神经元nmda受体(nmdar)与nmdar相互作用蛋白的相互作用的融合肽 | |
| JP2011518179A5 (https=) | ||
| US20110218149A1 (en) | Compositions and methods for treatment of kidney disorders | |
| JP2015504052A5 (https=) | ||
| JP2010536714A5 (https=) | ||
| JPWO2019156137A5 (https=) | ||
| JP2007535910A5 (https=) | ||
| AU2016277449B2 (en) | Protease-resistant lipidated GLP-1 analogs | |
| JP2024528407A5 (https=) | ||
| AU764218B2 (en) | Threonine-containing protegrins | |
| JP2020511425A5 (https=) | ||
| JP2022512770A5 (https=) | ||
| JPWO2016063969A1 (ja) | ヘマグルチニン結合ペプチド | |
| WO2008050133A2 (en) | Inhibition of beta-amyloid aggregation | |
| JP2002539829A5 (https=) | ||
| JP2023509187A5 (https=) | ||
| JP2021531246A5 (https=) | ||
| JP2023523719A5 (https=) |